EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Association Between Pulmonary Artery Pulsatility and Mortality After Implantation of Left Ventricular Assist Device

Ali Akamkam, Vincent Galand, Marie Jungling, Clément Delmas, Camille Dambrin, Mathieu Pernot, Michel Kindo, Philippe Gaudard, Philippe Rouviere, Thomas Senage, Olivier Chavanon, Marylou Para und 15 weitere

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14716 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Ali Akamkam und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, Le Plessis-Robinson, France. Hauptthemen laut MEDLINE: Heart-Assist Devices, Pulmonary Artery, Heart Failure. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Right ventricular failure after left ventricular assist device (LVAD) implantation is a major concern that remains challenging to predict. We sought to investigate the relationship between preoperative pulmonary artery pulsatility index (PAPi) and mortality after LVAD implantation. Methods and results A retrospective analysis of the ASSIST-ICD multicentre registry allowed the assessment of PAPi before LVAD according to the formula [(systolic pulmonary artery pressure − diastolic pulmonary artery pressure)/central venous pressure]. The primary endpoint was survival at 3 months, according to the threshold value of PAPi determined by the receiver operating characteristic (ROC) curve. A multivariate analysis including demographic, echographic, haemodynamic, and biological variables was performed to identify predictive factors for 2 year mortality. One hundred seventeen patients were included from 2007 to 2021. The mean age was 58.45 years (±13.16), with 15.4% of women (sex ratio 5.5). A total of 53.4% were implanted as bridge to transplant and 43.1% as destination therapy. Post-operative right ventricular failure was observed in 57 patients (48.7%), with no significant difference between survivors and non-survivors at 1 month (odds ratio 1.59, P = 0.30). The median PAPi for the whole study population was 2.83 [interquartile range 1.63–4.69]. The threshold value of PAPi determined by the ROC curve was 2.84. Patients with PAPi ≥ 2.84 had a higher survival rate at 3 months [PAPi < 2.84: 58.1% [46.3–72.8%] vs. PAPi ≥ 2.84: 89.1% [81.1–97.7%], hazard ratio (HR) 0.08 [0.02–0.28], P < 0.01], with no significant difference after 3 months (HR 0.67 [0.17–2.67], P = 0.57). Other predictors of 2 year mortality were systemic hypertension (HR 4.22 [1.49–11.97], P < 0.01) and diabetes mellitus (HR 4.90 [1.83–13.14], P < 0.01). LVAD implantation as bridge to transplant (HR 0.18 [0.04–0.74], P = 0.02) and heart transplantation (HR 0.02 [0.00–0.18], P < 0.01) were associated with a higher survival rate at 2 years.

Conclusions

Preoperative PAPi < 2.84 was associated with a higher risk of early mortality after LVAD implantation without impacting 2 year outcomes among survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesPulmonary ArteryHeart FailureHumansFemaleMaleMiddle AgedRetrospective StudiesPulsatile FlowSurvival RateFollow-Up StudiesRegistriesVentricular Dysfunction, Right

Stichwörter der Autor:innen

Circulatory assist devicesDatabaseHaemodynamicsHeart failureLeft ventricular assist deviceVentricle, right

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, Le Plessis-Robinson, France.
  • Department of Cardiology, University of Rennes, CHU Rennes, Rennes, France.
  • Department of Cardiac Surgery, Lille University Hospital, Heart-Lung Institute, Lille, France.
  • Department of Cardiology, University Hospital of Toulouse, Toulouse, France.
  • Department of Cardiovascular Surgery, University Hospital of Toulouse, Toulouse, France.
  • Haut-Lévêque Cardiological Hospital, Bordeaux II University, Bordeaux, France.

Zitieren

APA

Akamkam, A., Galand, V., Jungling, M., Delmas, C., Dambrin, C., Pernot, M., Kindo, M., Gaudard, P., Rouviere, P., Senage, T., Chavanon, O., Para, M., Gariboldi, V., Pozzi, M., Litzler, P. Y., Babatasi, G., Bouchot, O., Radu, C., Bourguignon, T., …, & Guihaire, J. (2024). Association Between Pulmonary Artery Pulsatility and Mortality After Implantation of Left Ventricular Assist Device. ESC Heart Failure. https://doi.org/10.1002/ehf2.14716

Vancouver

Akamkam A, Galand V, Jungling M, Delmas C, Dambrin C, Pernot M, et al. Association Between Pulmonary Artery Pulsatility and Mortality After Implantation of Left Ventricular Assist Device. ESC Heart Failure. 2024. doi:10.1002/ehf2.14716

BibTeX
@article{Akamkam2024,
  author = {Akamkam, Ali and Galand, Vincent and Jungling, Marie and Delmas, Clément and Dambrin, Camille and Pernot, Mathieu and Kindo, Michel and Gaudard, Philippe and Rouviere, Philippe and Senage, Thomas and Chavanon, Olivier and Para, Marylou and Gariboldi, Vlad and Pozzi, Matteo and Litzler, Pierre-Yves and Babatasi, Gerard and Bouchot, Olivier and Radu, Costin and Bourguignon, Thierry and D'Ostrevy, Nicolas and Abi Akar, Ramzi and Vanhuyse, Fabrice and Gaillard, Maïra and Chatelier, Gilles and Fels, Audrey and Flecher, Erwan and Guihaire, Julien},
  title = {Association Between Pulmonary Artery Pulsatility and Mortality After Implantation of Left Ventricular Assist Device},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14716}
}
Kostenlos starten →